
Alexander Kutikov MD FACS
Minimally Invasive Surgery, Surgical Oncology
Co-Executive Director, Fox Chase - Temple Urologic Institute Chair, Fox Chase Cancer Center Department of Urology Roberta R. Scheller Endowed Chair in Urologic Oncology Professor, Fox Chase Cancer Center Professor, Lewis Katz School of Medicine, Temple University
Join to View Full Profile
333 Cottman AvenueFox Chase Cancer CenterPhiladelphia, PA 19111
Phone+1 215-728-6900
Fax+1 215-214-1734
Dr. Kutikov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Alexander Kutikov, MD, FACS, is Co-Executive Director of the Fox Chase–Temple Urologic Institute and Chair of the Department of Urology at Fox Chase Cancer Center in Philadelphia, where he holds the Roberta R. Scheller Endowed Chair in Urologic Oncology. A board-certified urologic surgical oncologist, he leads one of the Northeast’s busiest urology and urologic oncology practices, specializing in robotic, laparoscopic, and complex open surgery for genitourinary cancers.
An internationally recognized academic surgeon, Dr. Kutikov has authored more than 300 peer-reviewed publications, including the widely adopted R.E.N.A.L. Nephrometry Score for kidney tumors. Under his leadership, the Fox Chase Urology group expanded into a full Department and helped form the Fox Chase–Temple Urologic Institute, contributing to the program’s rise into the top 20 in Urology rankings by U.S. News & World Report.
Dr. Kutikov trained in the Harvard–MIT Health Sciences and Technology Program at Harvard Medical School, completed residency at the University of Pennsylvania, and fellowship training in urologic oncology at Fox Chase Cancer Center.
Education & Training
Fox Chase Cancer CenterFellowship, Urologic Surgical Oncology, 2008 - 2010
University of Pennsylvania Health SystemChief Residency, Urology, 2007 - 2008
University of Pennsylvania Health SystemResidency, Urology, 2004 - 2007
University of Pennsylvania Health SystemInternship, Urology, 2003 - 2004
Harvard Medical SchoolClass of 2003
Certifications & Licensure
NJ State Medical License 2009 - 2027
PA State Medical License 2003 - 2026
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
Clinical Trials
- Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder Start of enrollment: 2016 Nov 11
Publications & Presentations
PubMed
- Impact of ischaemia duration and clamping strategy in patients with solitary kidney undergoing partial nephrectomy.Francesco Cei, Daniele Cignoli, Irene Franco, Koon Ho Rha, Christian Wagner
BJU International. 2026-03-01 - Beyond the Policy Cliff: Preserving Telemedicine for the Future.Randall A Lee, Jay Simhan, Alexander Kutikov
The Journal of Urology. 2026-02-17 - Gender Disparities in Citations and Altmetric Attention Score in Oncology.Rebecca A Campbell, Emma Helstrom, Lauren Chew, Renu Eapen, Elizabeth Plimack
JCO Oncology Practice. 2026-02-01
Journal Articles
- Assessment of Volume Preservation Performed Before or After Partial Nephrectomy Accurately Predicts Postoperative Renal Function: Results from a Prospective Multicente...Alexander Kutikov, Robert G Uzzo, Brian R Lane, Urologic Oncology
- Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid FeaturesRichard E Greenberg, Rosalia Viterbo, Timothy Ito, Marc C Smaldone, Joseph R Testa, Philip H Abbosh, Robert G Uzzo, Alexander Kutikov, The Journal of Urology
- Testicular Compartment Syndrome: A New Approach to Conceptualizing and Managing Testicular Torsion.Kutikov A, Casale P, White MA, Mayer WA, Chang A, Gozalbez R, Canning DA., Urology
Books/Book Chapters
Abstracts/Posters
- mTOR pathway activation in primary renal cell carcinoma and match metastases.Kutikov A, Egleston BL, Morrison T, Henske EP, Huang M, Al-Saleem T, Uzzo RG., American Urological Association Meeting, Chicago, IL
- Routine Adrenalectomy is Unnecessary During Surgery for Renal Cell Carcinoma – Event for Large and/or Upper Pole Tumors.Kutikov A, Piotrowski Z, Canter DJ, Kister DL, Litwin S, Chen DYT, Viterbo R, Greenberg RE, Boorjian SA, Uzzo RG., American Urological Association Meeting, San Fransisco, CA
- Anatomical Features of Enhancing Renal Masses Predict Histology and Grade – an Analysis Using Nephrometry.Kutikov A, Manley BJ, Canter DJ, Egleston BL, Kister DL, Chen DYT, Greenberg RE, Boorjian SA, Viterbo R, Uzzo RG., American Urological Association Meeting, San Francisco, CA
Lectures
- Management of Adrenal Incidentaloma in the Patient with Cancer.Temple University General Surgery Grand Rounds
- Moderator for Podium Session on Urologic Oncology.Mid-Atlantic New England AUA Sectional Meeting, Orlando, FL
- Adrenal Mass in the Cancer Patient.University of Pennsylvania Urology Grand Rounds
Authored Content
- The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: A Real World Multi-Institutional AnalysisFebruary 2022
Press Mentions
Global Burden of Renal Cancer Expected to Double by 2050October 21st, 2025
Kidney Cancer Cases Are Expected to Double by 2050, Study FindsSeptember 30th, 2025
Kidney Cancer Cases to Double by 2050: 5 Warning Signs You Should Not IgnoreSeptember 29th, 2025
Professional Memberships
- Member
- Member
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









